Erratum: Intra-hippocampal transplantation of neural precursor cells with transgenic over-expression of IL-1 receptor antagonist rescues memory and neurogenesis impairments in an Alzheimer's disease model (Neuropsychopharmacology (2014) 39 (411-424) doi:10.1038/npp.2013.208);Intra-hippocampal transplantation of neural precursor cells with transgenic over-expression of IL-1 receptor antagonist rescues memory and neurogenesis impairments in an alzheimer's disease model

Neuropsychopharmacology

Volumn 39, Issue 2, 2014, Pages 401-414

  Ben Menachem Zidon, Ofra ^a   Menahem, Yair Ben ^a   Hur, Tamir Ben ^b   Yirmiya, Raz ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Alzheimer's disease; hippocampus; interleukin 1; microglia; neural precursor cells; neurogenesis

Indexed keywords

ANTIINFLAMMATORY AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MESSENGER RNA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN FUNCTION; BRAIN TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFECT; GENE OVEREXPRESSION; HIPPOCAMPUS; MALE; MOUSE; MOUSE MODEL; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; SPATIAL MEMORY; TG2576 MOUSE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MEMORY; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; NEURAL STEM CELLS; NEUROGENESIS; NEURONS;

EID: 84890565652     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.264     Document Type: Erratum

References (62)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM et al (2000). Inflammation and Alzheimer's disease. Neurobiol Aging 21: 383-421.
2. Allan SM, Tyrrell PJ, Rothwell NJ (2005). Interleukin-1 and neuronal injury. Nat Rev Immunol 5: 629-640.
3. Avital A, Goshen I, Kamsler A, Segal M, Iverfeldt K, Richter-Levin G et al (2003). Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13: 826-834.
4. Barrientos RM, Sprunger DB, Campeau S, Higgins EA, Watkins LR Rudy JW et al (2003). Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 121: 847-853.
5. Barrientos RM, Sprunger DB, Campeau S, Watkins LR, Rudy JW Maier SF (2004). BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1beta administration. J Neuroimmunol 155: 119-126.
6. Ben Menachem-Zidon O, Avital A, Ben-Menahem Y, Goshen I Kreisel T, Shmueli EM et al (2011). Astrocytes support hippocampal-dependent memory and long-term potentiation via interleukin-1 signaling. Brain Behav Immun 25: 1008-1016.
7. Ben Menachem-Zidon O, Goshen I, Kreisel T, Ben Menahem Y Reinhartz E, Ben Hur T et al (2008). Intrahippocampal transplantation of transgenic neural precursor cells overexpressing interleukin-1 receptor antagonist blocks chronic isolation-induced impairment in memory and neurogenesis. Neuropsychopharmacology 33: 2251-2262.
8. Ben-Hur T, Ben-Menachem O, Furer V, Einstein O, Mizrachi-Kol R, Grigoriadis N (2003). Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells. Mol Cell Neurosci 24: 623-631.
9. Blank T, Prinz M (2013). Microglia as modulators of cognition and neuropsychiatric disorders. Glia 61: 62-70.
10. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA Muller FJ, Loring JF et al (2009). Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci USA 106: 13594-13599.
11. Chen WW, Blurton-Jones M (2012). Concise review: can stem cells be used to treat or model Alzheimer's disease? Stem Cells 30: 2612-2618.
12. De Feo D, Merlini A, Laterza C, Martino G (2012). Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection. Curr Opin Neurol 25: 322-333.
13. Ekdahl CT, Kokaia Z, Lindvall O (2009). Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158: 1021-1029.
14. Fainstein N, Einstein O, Cohen ME, Brill L, Lavon I, Ben-Hur T (2013). Time limited immunomodulatory functions of transplanted neural precursor cells. Glia 61: 140-149.
15. Farfara D, Lifshitz V, Frenkel D (2008). Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease. J Cell Mol Med 12: 762-780.
16. Ghosh S,Wu MD, Shaftel SS, Kyrkanides S, LaFerla FM, Olschowka JA et al (2013). Sustained interleukin-1b overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model. J Neurosci 33: 5053-5064.
17. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010). Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
18. Golde TE, Schneider LS, Koo EH (2011). Anti-ab therapeutics in Alzheimer's disease: the need for a paradigm shift. Neuron 69: 203-213.
19. Goldgaber D, Harris HW, Hla T, Maciag T, Donnelly RJ Jacobsen JS et al (1989). Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 86: 7606-7610.
20. Goshen I, Avital A, Kreisel T, Licht T, Segal M, Yirmiya R (2009a). Environmental enrichment restores memory functioning in mice with impaired IL-1 signaling via reinstatement of longterm potentiation and spine size enlargement. J Neurosci 29: 3395-3403.
21. Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T Weidenfeld J, Ben-Hur T et al (2008). Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 13: 717-728.
22. Goshen I, Yirmiya R (2009b). Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol 30: 30-45.
23. Griffin WS (2011). Alzheimer's-looking beyond plaques. F1000 Med Rep 3: 24.
24. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ et al (1989). Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86: 7611-7615.
25. Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira Saecker A et al (2013). NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493: 674-678.
26. Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A Dumitrescu-Ozimek L, Terwel D et al (2010a). Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci USA 107: 6058-6063.
27. Heneka MT, O'Banion MK, Terwel D, Kummer MP (2010b). Neuroinflammatory processes in Alzheimer's disease. J Neural Transm 117: 919-947.
28. Hernández-Rabaza V, Llorens-Mart?́n M, Velázquez- Sánchez C Ferragud A, Arcusa A, Gumus HG et al (2009). Inhibition of adult hippocampal neurogenesis disrupts contextual learning but spares spatial working memory, long-term conditional rule retention and spatial reversal. Neuroscience 159: 59-68.
29. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S et al (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99-102.
30. Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT (1997). APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56: 965-973.
31. Karran E, Mercken M, De Strooper B (2011). The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10: 698-712.
32. Kempermann G, Kuhn HG, Gage FH (1997). Genetic influence on neurogenesis in the dentate gyrus of adult mice. Proc Natl Acad Sci USA 94: 10409-10414.
33. Kim TK, Lee JE, Park SK, Lee KW, Seo JS, Im JY et al (2012). Analysis of differential plaque depositions in the brains of Tg2576 and Tg-APPswe/PS1dE9 transgenic mouse models of Alzheimer disease. Exp Mol Med 44: 492-502.
34. Kitazawa M, Cheng D, Tsukamoto MR, Koike MA, Wes PD Vasilevko V et al (2011). Blocking IL-1 Signaling rescues cognition, attenuates tau pathology, and restores neuronal beta-catenin pathway function in an Alzheimer's disease model. J Immunol 187: 6539-6549.
35. Koo JW, Duman RS (2008). IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA 105: 751-756.
36. Lee CY, Landreth GE (2010). The role of microglia in amyloid clearance from the AD brain. J Neural Transm 117: 949-960.
37. Li Y, Liu L, Barger SW, Griffin WS (2003). Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38 MAPK pathway. J Neurosci 23: 1605-1611.
38. Li Y, Liu L, Kang J, Sheng JG, Barger SW, Mrak RE et al (2000). Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci 20: 149-155.
39. Lu Y, Wu X, Dong Y, Xu Z, Zhang Y, Xie Z (2010). Anesthetic sevoflurane causes neurotoxicity differently in neonatal naive and Alzheimer disease transgenic mice. Anesthesiology 112: 1404-1416.
40. Lundkvist J, Sundgren-Andersson AK, Tingsborg S, Ostlund P Engfors C, Alheim K et al (1999). Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist. Am J Physiol 276(3 Pt 2): R644-R651.
41. Lynch MA (2009). The multifaceted profile of activated microglia. Mol Neurobiol 40: 139-156.
42. Matousek SB, Ghosh S, Shaftel SS, Kyrkanides S, Olschowka JA O'Banion MK (2012). Chronic IL-1b-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration. J Neuroimmune Pharmacol 7: 156-164.
43. McAfoose J, Baune BT (2009). Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 33: 355-366.
44. McGeer EG, McGeer PL (2003). Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27: 741-749.
45. Medeiros R, Kitazawa M, Passos GF, Baglietto-Vargas D, Cheng D Cribbs DH et al (2013). Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice. Am J Pathol 182: 1780-1789.
46. Meshi D, Drew MR, Saxe M, Ansorge MS, David D, Santarelli L et al (2006). Hippocampal neurogenesis is not required for behavioral effects of environmental enrichment. Nat Neurosci 9: 729-731.
47. Mu Y, Gage FH (2011). Adult hippocampal neurogenesis and its role in Alzheimer's disease. Mol Neurodegener 6: 85.
48. Nagahara AH, Tuszynski MH (2011). Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov 10: 209-219.
49. Oprica M, Hjorth E, Spulber S, Popescu BO, Ankarcrona M Winblad B et al (2007). Studies on brain volume, Alzheimerrelated proteins and cytokines in mice with chronic overexpression of IL-1 receptor antagonist. J Cell Mol Med 11: 810-825.
50. Pollak Y, Gilboa A, Ben-Menachem O, Ben-Hur T, Soreq H Yirmiya R (2005). Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production. Ann Neurol 57: 741-745.
51. Rachal Pugh C, Fleshner M, Watkins LR, Maier SF, Rudy JW (2001). The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci Biobehav Rev 25: 29-41.
52. Rainero I, Bo M, Ferrero M, Valfre W, Vaula G, Pinessi L (2004). Association between the interleukin-1alpha gene and Alzheimer's disease: a meta-analysis. Neurobiol Aging 25: 1293-1298.
53. Shaftel SS, Griffin WS, O'Banion MK (2008). The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 5: 7.
54. Shaftel SS, Kyrkanides S, Olschowka JA, Miller JN, Johnson RE O'Banion MK (2007). Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest 117: 1595-1604.
55. Sheng JG, Ito K, Skinner RD, Mrak RE, Rovnaghi CR, Van Eldik LJ et al (1996). In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging 17: 761-766.
56. Shruster A, Melamed E, Offen D (2010). Neurogenesis in the aged and neurodegenerative brain. Apoptosis 15: 1415-1421.
57. Tachida Y, Nakagawa K, Saito T, Saido TC, Honda T, Saito Y et al (2008). Interleukin-1 beta up-regulates TACE to enhance alphacleavage of APP in neurons: resulting decrease in Abeta production. J Neurochem 104: 1387-1393.
58. Tang JX, Mardini F, Janik LS, Garrity ST, Li RQ, Bachlani G et al (2013). Modulation of murine Alzheimer pathogenesis and behavior by surgery. Ann Surg 257: 439-448.
59. Tong L, Balazs R, Soiampornkul R, Thangnipon W, Cotman CW (2008). Interleukin-1 beta impairs brain derived neurotrophic factor-induced signal transduction. Neurobiol Aging 29: 1380-1393.
60. Weitz TM, Town T (2012). Microglia in Alzheimer's Disease: It's All About Context. Int J Alzheimers Dis 2012: 314185.
61. Wu MD, Hein AM, Moravan MJ, Shaftel SS, Olschowka JA O'Banion MK (2012). Adult murine hippocampal neurogenesis is inhibited by sustained IL-1b and not rescued by voluntary running. Brain Behav Immun 26: 292-300.
62. Yirmiya R, Goshen I (2011). Immune modulation of learning memory, neural plasticity and neurogenesis. Brain Behav Immun 25: 181-213.